PREG and PME promote microtubule dynamics by possibly affecting the microtubule‐binding of MAP2 and the plus‐end tracking protein CLIP170 with possible therapeutic potential for major depressive disorders and CDKL5 deficiency disorder, both characterised by altered microtubule dynamics. The gene discussed is MAP2; the disease is major depressive disorder.